InvestorsHub Logo
icon url

kld2

08/08/17 6:59 AM

#114368 RE: biotechrocks #114366

bio, your question is a propos. Why haven't they? And why has the share price continued to plummet? There really are no secrets in any of this, only patterns that begin to emerge after long periods of secrecy and obfuscation. Welcome to biotech, where there are no patron saints of retail investors. I don't know exactly what Anavex has, nor does anyone else, but I guarantee you, if they had the drug of the century, you would know it.
icon url

eagle8

08/08/17 7:08 AM

#114369 RE: biotechrocks #114366


As discussed here on the board : probably because of the A2-73 PLUS patent and the IP involved.
So the road looks clear now for one (or more) deal (?)


GLTU
icon url

falconer66a

08/08/17 7:30 AM

#114373 RE: biotechrocks #114366

Missling Not Selling (Thankfully)

Would think they're also aware of its potential and would look to grab it away for about 1.5 billion today (10x).



Missling sees the big picture, a decade down the road, when, by itself, Anavex will match or eclipse any Big Pharmaceutical.

Long term, not short term profits; of orders of magnitude increase.